We investigate drug metabolites through exploratory and in-depth metabolite profiling and characterisation studies using liquid chromatography and high-resolution mass spectrometry with or without online or offline radioactivity monitoring. This is done to support Metabolites in Safety Testing evaluations and to understand the fate of the drug.